Clearmind Medicine CMND
NASDAQ CMND
$1.74 +0.01 (+0.85%)
As of: Aug 21, 2026 · 3:59 PM EDT

Clearmind Medicine (CMND) Debt Ratio (2021 - 2026)

Clearmind Medicine (CMND) posted quarterly Debt Ratio of 0.01 for Q2 2026, down 29.17% year-over-year from 0.01 in Q2 2025, and down 67.04% quarter-over-quarter from 0.02 in Q1 2026.

Clearmind Medicine (CMND) Debt Ratio (2021 - 2026) Analysis & Trends

Clearmind Medicine's Debt Ratio history runs 6 years deep, the most recent figure standing at 0.01 for Q2 2026.

  • In Q2 2026, Debt Ratio fell 29.17% year-over-year to 0.01; the TTM figure through Apr 2026 stood at 0.01 (down 29.17% YoY), while the FY2025 annual figure was 0.01, up 46.73% from the prior year.
  • Debt Ratio for Q2 2026 stood at 0.01, down from 0.02 in the prior quarter.
  • The five-year high for Debt Ratio was 0.25 in Q4 2022, with the low at 0.01 in Q2 2024.
  • The 5-year median for Debt Ratio is 0.01 (2023), against an average of 0.03.
  • The sharpest annual moves came in 2022 and 2023: Debt Ratio soared 15506.08% in 2022, then tumbled 97.15% in 2023.
  • Clearmind Medicine's Debt Ratio stood at 0.25 in 2022, then sank by 97.15% to 0.01 in 2023, then retreated by 5.32% to 0.01 in 2024, then jumped by 46.73% to 0.01 in 2025, then tumbled by 31.99% to 0.01 in 2026.
  • Business Quant data shows CMND's Debt Ratio at 0.01 in Q2 2026, 0.02 in Q1 2026, and 0.01 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Clearmind Medicine 537,435.54 -13.06 Mn - 0.03

Historic Data

Download Data
DateValue
Apr 30, 2026 0.01
Jan 31, 2026 0.02
Oct 31, 2025 0.01
Jul 31, 2025 0.01
Apr 30, 2025 0.01
Jan 31, 2025 0.01
Oct 31, 2024 0.01
Jul 31, 2024 0.01
Apr 30, 2024 0.01
Jan 31, 2024 0.02
Oct 31, 2023 0.01
Jul 31, 2023 0.01
Jan 31, 2023 0.02
Oct 31, 2022 0.25
Oct 31, 2021 0.00